On ECHEMI
Home > Drugs > Osteoporosis
Osteoporosis
Osteoporosis is a systemic bone disease characterized by decreased bone mass and destruction of bone microstructure, which is manifested as increased bone brittleness, thus greatly increasing the risk of fractures. Fractures are prone to occur even with minor trauma or without trauma. Osteoporosis is a chronic disease caused by multiple factors. There are usually no special clinical manifestations before a fracture occurs. The disease affects more women than men and is common in postmenopausal women and the elderly. With the increase of the elderly population in my country, the incidence of osteoporosis is on the rise, which is a health issue worthy of attention in my country and even in the world.
  • Site of disease:

    bone
  • Infectious :

    Not contagious
  • Frequent population:

    Among all groups, the elderly are the most
  • Related symptoms:

    Extensive osteoporosis hunchback bone deformation and shortening thoracic vertebra deformity body skeletal muscle contraction
  • Concurrent disease:

Related Drugs
Calcium Gluconate Lozenges
Indication: Used to prevent and treat calcium deficiency diseases such as osteoporosis, tetany, bone dysplasia, rickets, and as calcium supplement for children, pregnant and lactating women, menopausal women, and the elderly.
Manufacturer:

Shanghai Huayuan Changfu Pharmaceutical Group Jingde Pharmaceutical Co., Ltd.

Calcium Gluconate Lozenges
Indication: Used to prevent and treat calcium deficiency diseases such as osteoporosis, tetany, bone dysplasia, rickets, and as calcium supplement for children, pregnant and lactating women, menopausal women, and the elderly.
Manufacturer:

Sinopharm Shantou Jinshi Pharmaceutical Co., Ltd.

Salmon calcitonin injection
Indication: 1 Early and late postmenopausal osteoporosis and senile osteoporosis where conventional estrogen combined with calcium preparations is contraindicated or cannot be used. 2 Hypercalcemia secondary to bone metastasis of breast cancer, lung cancer or kidney cancer, myeloma and other malignant tumors. 3 Osteitis deformans.
Manufacturer:

Beijing SL Pharmaceutical Co., Ltd.

Salmon calcitonin injection
Indication: 1 Early and late postmenopausal osteoporosis and senile osteoporosis where conventional estrogen combined with calcium preparations is contraindicated or cannot be used. 2 Hypercalcemia secondary to bone metastasis of breast cancer, lung cancer or kidney cancer, myeloma and other malignant tumors. 3 Osteitis deformans.
Manufacturer:

Guilin Pharmaceutical Co., Ltd.

Salmon calcitonin injection
Indication: 1 Early and late postmenopausal osteoporosis and senile osteoporosis where conventional estrogen combined with calcium preparations is contraindicated or cannot be used. 2 Hypercalcemia secondary to bone metastasis of breast cancer, lung cancer or kidney cancer, myeloma and other malignant tumors. 3 Osteitis deformans.
Manufacturer:

Guilin Pharmaceutical Co., Ltd.

Salmon calcitonin injection
Indication: 1. Early and late postmenopausal osteoporosis and senile osteoporosis where conventional estrogen combined with calcium preparations is contraindicated or cannot be used for treatment; 2. Hypercalcemia caused by bone metastasis of breast cancer, lung cancer or kidney cancer, myeloma and other malignant tumors; 3. Osteitis deformans.
Manufacturer:

Avanc Pharmaceutical Co., Ltd.

Elcatonin
Indication: Osteoporosis
Salmon Calcitonin Nasal Spray
Indication: 1. Osteoporosis: (1) Early and late postmenopausal osteoporosis; (2) Senile osteoporosis; (3) Secondary osteoporosis, for example: corticosteroid treatment or lack of activity. In order to prevent progressive bone loss, calcium and vitamin D should be taken in appropriate amounts according to individual needs. 2. Bone pain accompanied by osteolysis and/or osteopenia. 3. Paget’s disease (osteitis deformans), especially patients with the following conditions: (1) Bone pain; (2) Neurological complications; (3) Increased bone turnover, manifested by increased serum alkaline phosphatase and increased urinary hydroxyproline excretion; (4) Progressive spread of bone lesions; (5) Incomplete or recurrent fractures. 4. Hypercalcemia and hypercalcemic crisis caused by the following conditions: (1) Secondary breast cancer, lung or kidney cancer, bone
Manufacturer:

Beijing Jiashitang Biological Medicine Co., Ltd.

Alendronate Sodium Tablets
Indication: 1. For the treatment of osteoporosis in postmenopausal women. 2. For the prevention of hip and spinal fractures (vertebral compression fractures).
Manufacturer:

Shandong Lukang Group Saite Co., Ltd.

Alendronate Sodium Tablets
Indication: 1. For the treatment of osteoporosis in postmenopausal women. 2. For the prevention of hip and spinal fractures (vertebral compression fractures).
Manufacturer:

Shandong Lukang Group Saite Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.